USD 2.67
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 2.29 Million USD | -35.7% |
2022 | 3.57 Million USD | -30.29% |
2021 | 5.12 Million USD | -42.41% |
2020 | 8.9 Million USD | 49.19% |
2019 | 5.96 Million USD | 266.52% |
2018 | 1.62 Million USD | -51.79% |
2017 | 3.37 Million USD | -0.12% |
2016 | 3.38 Million USD | -42.61% |
2015 | 5.89 Million USD | -5.7% |
2014 | 6.24 Million USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | -100.0% |
1999 | 200 Thousand USD | 0.0% |
1998 | - USD | 0.0% |
1997 | - USD | 0.0% |
1996 | - USD | -100.0% |
1995 | 20 Thousand USD | -90.0% |
1994 | 200 Thousand USD | -33.33% |
1993 | 300 Thousand USD | 0.0% |
1992 | - USD | -100.0% |
1991 | 200 Thousand USD | -60.0% |
1990 | 500 Thousand USD | 0.0% |
1989 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 1.86 Million USD | -4.69% |
2024 Q1 | 1.96 Million USD | -14.71% |
2023 Q1 | 3.32 Million USD | -6.99% |
2023 FY | 2.29 Million USD | -35.7% |
2023 Q4 | 2.29 Million USD | -13.05% |
2023 Q3 | 2.64 Million USD | -11.49% |
2023 Q2 | 2.98 Million USD | -10.17% |
2022 Q4 | 3.57 Million USD | -8.94% |
2022 Q2 | 4.34 Million USD | -8.33% |
2022 Q1 | 4.74 Million USD | -7.55% |
2022 FY | 3.57 Million USD | -30.29% |
2022 Q3 | 3.92 Million USD | -9.67% |
2021 Q4 | 5.12 Million USD | -9.18% |
2021 Q2 | 8.24 Million USD | -5.03% |
2021 FY | 5.12 Million USD | -42.41% |
2021 Q1 | 8.68 Million USD | -2.48% |
2021 Q3 | 5.64 Million USD | -31.53% |
2020 Q1 | 5.56 Million USD | -6.82% |
2020 Q4 | 8.9 Million USD | -3.92% |
2020 FY | 8.9 Million USD | 49.19% |
2020 Q2 | 9.66 Million USD | 73.85% |
2020 Q3 | 9.26 Million USD | -4.15% |
2019 Q3 | 4.84 Million USD | 70.88% |
2019 Q1 | 3.12 Million USD | 91.89% |
2019 FY | 5.96 Million USD | 266.52% |
2019 Q4 | 5.96 Million USD | 23.08% |
2019 Q2 | 2.83 Million USD | -9.19% |
2018 Q2 | 2.89 Million USD | -7.62% |
2018 Q1 | 3.13 Million USD | -7.08% |
2018 FY | 1.62 Million USD | -51.79% |
2018 Q3 | 2.66 Million USD | -8.24% |
2018 Q4 | 1.62 Million USD | -38.8% |
2017 Q1 | 3.09 Million USD | -8.46% |
2017 Q3 | 1.47 Million USD | -8.41% |
2017 Q4 | 3.37 Million USD | 129.73% |
2017 FY | 3.37 Million USD | -0.12% |
2017 Q2 | 1.6 Million USD | -48.14% |
2016 Q4 | 3.38 Million USD | -35.3% |
2016 Q1 | 6.09 Million USD | 3.48% |
2016 Q3 | 5.22 Million USD | -7.69% |
2016 FY | 3.38 Million USD | -42.61% |
2016 Q2 | 5.66 Million USD | -7.14% |
2015 FY | 5.89 Million USD | -5.7% |
2015 Q3 | 6.29 Million USD | 13.49% |
2015 Q4 | 5.89 Million USD | -6.43% |
2015 Q2 | 5.54 Million USD | -5.93% |
2015 Q1 | 5.89 Million USD | -5.6% |
2014 Q1 | 1.05 Million USD | 0.0% |
2014 Q4 | 6.24 Million USD | -5.3% |
2014 Q3 | 6.59 Million USD | 10.94% |
2014 Q2 | 5.94 Million USD | 464.83% |
2014 FY | 6.24 Million USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2000 FY | - USD | -100.0% |
2000 Q4 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q1 | - USD | -100.0% |
2000 Q2 | - USD | 0.0% |
1999 FY | 200 Thousand USD | 0.0% |
1999 Q1 | - USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1999 Q4 | 200 Thousand USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1998 Q1 | - USD | 0.0% |
1998 FY | - USD | 0.0% |
1998 Q4 | - USD | 0.0% |
1998 Q3 | - USD | 0.0% |
1998 Q2 | - USD | 0.0% |
1997 Q2 | - USD | 0.0% |
1997 Q3 | - USD | 0.0% |
1997 FY | - USD | 0.0% |
1997 Q1 | - USD | 0.0% |
1997 Q4 | - USD | 0.0% |
1996 Q1 | - USD | -100.0% |
1996 Q2 | - USD | 0.0% |
1996 FY | - USD | -100.0% |
1996 Q4 | - USD | 0.0% |
1996 Q3 | - USD | 0.0% |
1995 Q2 | 100 Thousand USD | 0.0% |
1995 FY | 20 Thousand USD | -90.0% |
1995 Q3 | 100 Thousand USD | 0.0% |
1995 Q4 | 20 Thousand USD | -80.0% |
1995 Q1 | 100 Thousand USD | -50.0% |
1994 Q3 | 200 Thousand USD | 0.0% |
1994 Q1 | 200 Thousand USD | -33.33% |
1994 FY | 200 Thousand USD | -33.33% |
1994 Q2 | 200 Thousand USD | 0.0% |
1994 Q4 | 200 Thousand USD | 0.0% |
1993 Q1 | 400 Thousand USD | 0.0% |
1993 Q2 | 300 Thousand USD | -25.0% |
1993 Q3 | 300 Thousand USD | 0.0% |
1993 Q4 | 300 Thousand USD | 0.0% |
1993 FY | 300 Thousand USD | 0.0% |
1992 FY | - USD | -100.0% |
1992 Q1 | - USD | -100.0% |
1992 Q4 | - USD | 0.0% |
1991 Q4 | 200 Thousand USD | 0.0% |
1991 Q1 | 700 Thousand USD | 40.0% |
1991 FY | 200 Thousand USD | -60.0% |
1990 Q4 | 500 Thousand USD | 0.0% |
1990 FY | 500 Thousand USD | 0.0% |
1989 Q2 | - USD | 0.0% |
1989 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Bionano Genomics, Inc. | 87.94 Million USD | 97.387% |
Prenetics Global Limited | 2.36 Million USD | 3.013% |
Star Equity Holdings, Inc. | 3.6 Million USD | 36.326% |
CareDx, Inc | 34.22 Million USD | 93.285% |
Exact Sciences Corporation | 2.55 Billion USD | 99.91% |
Exagen Inc. | 23.72 Million USD | 90.312% |
Inotiv, Inc. | 417.64 Million USD | 99.45% |
Guardant Health, Inc. | 1.35 Billion USD | 99.83% |
Biodesix, Inc. | 60.69 Million USD | 96.214% |
BioNexus Gene Lab Corp. | 133.39 Thousand USD | -1622.703% |
Precipio, Inc. | 1.11 Million USD | -105.914% |
iSpecimen Inc. | 196.24 Thousand USD | -1070.991% |
Natera, Inc. | 441.99 Million USD | 99.48% |
Aspira Women's Health Inc. | 2.26 Million USD | -1.412% |
Standard BioTools Inc. | 98.21 Million USD | 97.66% |
23andMe Holding Co. | 76.51 Million USD | 96.997% |
Castle Biosciences, Inc. | 15.31 Million USD | 84.99% |
Personalis, Inc. | 48.96 Million USD | 95.307% |
Aclaris Therapeutics, Inc. | 426 Thousand USD | -439.437% |
Applied DNA Sciences, Inc. | 1.23 Million USD | -85.658% |
OpGen, Inc. | 13.04 Million USD | 82.382% |
T2 Biosystems, Inc. | 49.49 Million USD | 95.357% |
Myriad Genetics, Inc. | 145 Million USD | 98.415% |
ICON Public Limited Company | 3.93 Billion USD | 99.942% |
NeoGenomics, Inc. | 611.67 Million USD | 99.624% |
Star Equity Holdings, Inc. | 3.6 Million USD | 36.326% |
IDEXX Laboratories, Inc. | 947.88 Million USD | 99.758% |
RadNet, Inc. | 1.49 Billion USD | 99.846% |
MDxHealth SA | 41.26 Million USD | 94.431% |
Illumina, Inc. | 2.26 Billion USD | 99.898% |
Check-Cap Ltd. | - USD | -Infinity% |
Twist Bioscience Corporation | 94.06 Million USD | 97.557% |
DarioHealth Corp. | 29.54 Million USD | 92.221% |
Fulgent Genetics, Inc. | 14.9 Million USD | 84.584% |
Sera Prognostics, Inc. | 1.85 Million USD | -23.681% |
ENDRA Life Sciences Inc. | 394.4 Thousand USD | -482.653% |
OPKO Health, Inc. | 326.56 Million USD | 99.296% |
Medpace Holdings, Inc. | 142.12 Million USD | 98.383% |
Neogen Corporation | 906.23 Million USD | 99.746% |
Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -163.701% |
Prenetics Global Limited | 2.36 Million USD | 3.013% |
Mainz Biomed B.V. | 7.42 Million USD | 69.033% |
bioAffinity Technologies, Inc. | 1.57 Million USD | -45.568% |
Trinity Biotech plc | 67.42 Million USD | 96.592% |
Neuronetics, Inc. | 62.47 Million USD | 96.322% |
Sotera Health Company | 2.32 Billion USD | 99.901% |
bioAffinity Technologies, Inc. | 1.57 Million USD | -45.568% |